Xcenda, an AmerisourceBergen company, has just published a white paper that demonstrates the prevalence of step therapy and its potential negative impact on rheumatology patients. The authors of the report say the practice doesn’t always have the best interest of patents in mind and payers don't entirely disagree. Learn more in this report.
In this month's rheumatoid arthritis quiz, we focus on tests used to diagnose rheumatoid arthritis. Plus, is it DXA or DEXA? (©Kentoh,AdobeStock,279475413); (©Valentina,AdobeStock_296476228)